Neuca S.A.
ISIN: PLTRFRM00018 | Ticker: NEU | LEI: 259400KFX90IZ97UDQ91
Country: Poland
We are the market leader in the wholesale distribution of pharmaceutical products in Poland. Key partners for us are independent pharmacists, whom we recognize as the foundation for the development and stability of the pharmacy market. We support them in their daily pharmacy operations, providing tools to build competitiveness and profitability.
We take care of patients' health by developing a network of medical clinics. We are experts in the segment of clinical trials, we carry out ambitious telemedical projects and successfully operate in the e-commerce sector. We are also an experienced manufacturer of medicines and pharmaceutical preparations
Since 2004, NEUCA has been a public company, listed on the Warsaw Stock Exchange, regularly improving its financial results.
1990
Served areaEurope
HeadquartersForteczna 35-37, 87-100 Toruń – Poland
| Line item in (pln) | 02.01.2019 | 01.01.2020 | 02.01.2020 | 01.01.2021 | 02.01.2021 | 01.01.2022 | 01.01.2023 |
|---|---|---|---|---|---|---|---|
| Assets | 3,256,025,000.00 | 3,451,219,000.00 | 3,451,219,000.00 | 3,641,707,000.00 | 3,636,875,000.00 | 4,117,168,000.00 | 4,839,620,000.00 |
| Noncurrent Assets | 976,613,000.00 | 1,054,554,000.00 | 1,054,554,000.00 | 1,220,569,000.00 | 1,215,737,000.00 | 1,496,708,000.00 | 1,573,989,000.00 |
| Property Plant And Equipment | 285,683,000.00 | 349,646,000.00 | 349,646,000.00 | 401,279,000.00 | 401,279,000.00 | 391,052,000.00 | 427,263,000.00 |
| Investment Property | 39,952,000.00 | 38,987,000.00 | 38,987,000.00 | 35,298,000.00 | 35,298,000.00 | 22,867,000.00 | 19,944,000.00 |
| Goodwill | 301,354,000.00 | 309,212,000.00 | 309,212,000.00 | 427,887,000.00 | 427,887,000.00 | 649,439,000.00 | 726,469,000.00 |
| Intangible Assets Other Than Goodwill | 76,915,000.00 | 90,329,000.00 | 90,329,000.00 | 109,639,000.00 | 109,639,000.00 | 125,423,000.00 | 132,802,000.00 |
| Investment Accounted For Using Equity Method | 5,983,000.00 | 4,694,000.00 | 4,694,000.00 | 21,594,000.00 | 21,594,000.00 | 22,267,000.00 | 2,164,000.00 |
| Noncurrent Receivables | 52,098,000.00 | 55,939,000.00 | 55,939,000.00 | 46,431,000.00 | 41,599,000.00 | 39,040,000.00 | 10,845,000.00 |
| Deferred Tax Assets | 2,300,000.00 | 0.00 | N/A | 0.00 | N/A | N/A | N/A |
| Other Noncurrent Financial Assets | N/A | N/A | 0.00 | 0.00 | 0.00 | 16,098,000.00 | 0.00 |
| Current Assets | 2,279,412,000.00 | 2,396,665,000.00 | 2,396,665,000.00 | 2,421,138,000.00 | 2,421,138,000.00 | 2,620,460,000.00 | 3,265,631,000.00 |
| Inventories | 1,118,370,000.00 | 1,085,873,000.00 | 1,085,873,000.00 | 1,200,913,000.00 | 1,200,913,000.00 | 1,198,070,000.00 | 1,303,335,000.00 |
| Trade And Other Current Receivables | 1,093,490,000.00 | 1,178,906,000.00 | 1,178,906,000.00 | 1,140,813,000.00 | 1,140,813,000.00 | 1,289,023,000.00 | 1,683,196,000.00 |
| Current Tax Assets Current | 5,473,000.00 | 6,149,000.00 | 6,149,000.00 | 4,721,000.00 | 4,721,000.00 | 2,237,000.00 | 4,024,000.00 |
| Other Current Financial Assets | N/A | N/A | 0.00 | 0.00 | 0.00 | 24,620,000.00 | 17,452,000.00 |
| Cash and cash equivalents | 32,602,000.00 | 78,914,000.00 | 78,914,000.00 | 22,606,000.00 | 22,606,000.00 | 64,561,000.00 | 208,415,000.00 |
| Current Assets Other Than Assets Or Disposal Groups Classified As Held For Sale Or As Held For Distribution To Owners | 2,279,412,000.00 | 2,396,665,000.00 | 2,396,665,000.00 | 2,421,138,000.00 | 2,421,138,000.00 | 2,620,460,000.00 | 3,265,631,000.00 |
| Noncurrent Assets Or Disposal Groups Classified As Held For Sale Or As Held For Distribution To Owners | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity And Liabilities | 3,256,025,000.00 | 3,451,219,000.00 | 3,451,219,000.00 | 3,641,707,000.00 | 3,636,875,000.00 | 4,117,168,000.00 | 4,839,620,000.00 |
| Equity | 637,298,000.00 | 643,620,000.00 | 643,620,000.00 | 771,413,000.00 | 766,581,000.00 | 879,684,000.00 | 930,542,000.00 |
| Issued Capital | 4,533,000.00 | 4,562,000.00 | 4,562,000.00 | 4,387,000.00 | 4,387,000.00 | 4,432,000.00 | 4,445,000.00 |
| Retained Earnings | 438,825,000.00 | 523,967,000.00 | 523,967,000.00 | 525,910,000.00 | 521,078,000.00 | 609,584,000.00 | 640,045,000.00 |
| Share Premium | 188,521,000.00 | 195,564,000.00 | 195,564,000.00 | 240,672,000.00 | 240,672,000.00 | 262,998,000.00 | 284,380,000.00 |
| Treasury Shares | 12,379,000.00 | 100,635,000.00 | 100,635,000.00 | 18,237,000.00 | 18,237,000.00 | 54,961,000.00 | 73,296,000.00 |
| Other Reserves | 16,531,000.00 | 18,772,000.00 | 18,772,000.00 | 13,625,000.00 | 13,625,000.00 | 20,405,000.00 | 24,665,000.00 |
| Equity Attributable To Owners Of Parent | 636,031,000.00 | 642,230,000.00 | 642,230,000.00 | 766,357,000.00 | 761,525,000.00 | 842,458,000.00 | 880,239,000.00 |
| Noncontrolling Interests | 1,267,000.00 | 1,390,000.00 | 1,390,000.00 | 5,056,000.00 | 5,056,000.00 | 37,226,000.00 | 50,303,000.00 |
| Liabilities | 2,618,727,000.00 | 2,807,599,000.00 | 2,807,599,000.00 | 2,870,294,000.00 | 2,870,294,000.00 | 3,237,484,000.00 | 3,909,078,000.00 |
| Noncurrent Liabilities | 195,669,000.00 | 152,592,000.00 | 152,592,000.00 | 323,631,000.00 | 323,631,000.00 | 389,929,000.00 | 341,265,000.00 |
| Noncurrent Provisions For Employee Benefits | 1,208,000.00 | 1,650,000.00 | 1,650,000.00 | 1,942,000.00 | 1,942,000.00 | 2,473,000.00 | 2,898,000.00 |
| Noncurrent Payables | 1,593,000.00 | 1,125,000.00 | 1,125,000.00 | 2,053,000.00 | 2,053,000.00 | 3,472,000.00 | 4,526,000.00 |
| Deferred Tax Liabilities | 0.00 | 10,754,000.00 | 10,754,000.00 | 14,320,000.00 | 14,320,000.00 | 6,811,000.00 | 4,904,000.00 |
| Other Noncurrent Financial Liabilities | 0.00 | 0.00 | 0.00 | 96,119,000.00 | 96,119,000.00 | 92,909,000.00 | 90,711,000.00 |
| Longterm Borrowings | 45,029,000.00 | 0.00 | 0.00 | 598,000.00 | 598,000.00 | 4,736,000.00 | 5,859,000.00 |
| Current Liabilities | 2,423,058,000.00 | 2,655,007,000.00 | 2,655,007,000.00 | 2,546,663,000.00 | 2,546,663,000.00 | 2,847,555,000.00 | 3,567,813,000.00 |
| Current Provisions For Employee Benefits | 6,001,000.00 | 6,541,000.00 | 6,541,000.00 | 7,556,000.00 | 7,556,000.00 | 8,957,000.00 | 11,239,000.00 |
| Other Shortterm Provisions | 1,593,000.00 | 1,955,000.00 | 1,955,000.00 | 1,923,000.00 | 1,923,000.00 | 3,152,000.00 | 1,056,000.00 |
| Trade And Other Current Payables | 2,249,526,000.00 | 2,309,495,000.00 | 2,309,495,000.00 | 2,432,978,000.00 | 2,432,978,000.00 | 2,596,799,000.00 | 3,109,651,000.00 |
| Current Tax Liabilities Current | 2,184,000.00 | 10,351,000.00 | 10,351,000.00 | 10,123,000.00 | 10,123,000.00 | 31,488,000.00 | 7,357,000.00 |
| Other Current Financial Liabilities | 0.00 | 0.00 | 0.00 | 3,438,000.00 | 3,438,000.00 | 3,307,000.00 | 2,940,000.00 |
| Current Liabilities Other Than Liabilities Included In Disposal Groups Classified As Held For Sale | 2,423,058,000.00 | 2,655,007,000.00 | 2,655,007,000.00 | 2,546,663,000.00 | 2,546,663,000.00 | 2,847,555,000.00 | 3,567,813,000.00 |
| Liabilities Included In Disposal Groups Classified As Held For Sale | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Current Borrowings And Current Portion Of Noncurrent Borrowings | 132,530,000.00 | 290,585,000.00 | 290,585,000.00 | 13,630,000.00 | 13,630,000.00 | 19,876,000.00 | 196,597,000.00 |
| Line item in (pln) | 01.01.2019/ 01.01.2020 |
01.01.2020/ 01.01.2021 |
01.01.2021/ 01.01.2022 |
01.01.2022/ 01.01.2023 |
|---|---|---|---|---|
| Revenue | 8,272,365,000.00 | 9,244,887,000.00 | 9,864,258,000.00 | 11,232,540,000.00 |
| Other Income | 7,332,000.00 | 13,036,000.00 | 18,681,000.00 | 39,047,000.00 |
| Profit Loss From Operating Activities | 156,692,000.00 | 212,071,000.00 | 198,189,000.00 | 241,328,000.00 |
| Finance Income | 13,703,000.00 | 12,107,000.00 | 21,166,000.00 | 17,325,000.00 |
| Finance Costs | 14,562,000.00 | 28,545,000.00 | 17,292,000.00 | 56,533,000.00 |
| Impairment Loss Impairment Gain And Reversal Of Impairment Loss Determined In Accordance With I F R S9 | 5,845,000.00 | 14,834,000.00 | 6,780,000.00 | -1,279,000.00 |
| Share Of Profit Loss Of Associates And Joint Ventures Accounted For Using Equity Method | -1,288,000.00 | -2,185,000.00 | 170,000.00 | -169,000.00 |
| Other Income Expense From Subsidiaries Jointly Controlled Entities And Associates | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit Loss Before Tax | 154,545,000.00 | 193,448,000.00 | 202,233,000.00 | 201,951,000.00 |
| Income Tax Expense Continuing Operations | 37,092,000.00 | 50,188,000.00 | 49,683,000.00 | 54,359,000.00 |
| Profit Loss From Continuing Operations | 117,453,000.00 | 143,260,000.00 | 152,550,000.00 | 147,592,000.00 |
| Profit Loss From Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit (loss) | 117,453,000.00 | 143,260,000.00 | 152,550,000.00 | 147,592,000.00 |
| Profit Loss Attributable To Owners Of Parent | 117,265,000.00 | 141,791,000.00 | 150,655,000.00 | 136,355,000.00 |
| Profit Loss Attributable To Noncontrolling Interests | 188,000.00 | 1,469,000.00 | 1,895,000.00 | 11,237,000.00 |
| Line item in (pln) | 01.01.2020 | 02.01.2019 | 01.01.2021 | 02.01.2020 | 01.01.2022 | 02.01.2021 | 01.01.2023 |
|---|---|---|---|---|---|---|---|
| Profit (loss) | 117,453,000.00 | N/A | 143,260,000.00 | N/A | 152,550,000.00 | N/A | 147,592,000.00 |
| Adjustments For Reconcile Profit Loss | 71,584,000.00 | N/A | 172,152,000.00 | N/A | 129,737,000.00 | N/A | 214,172,000.00 |
| Adjustments For Decrease Increase In Inventories | 32,497,000.00 | N/A | -115,760,000.00 | N/A | -24,244,000.00 | N/A | -91,306,000.00 |
| Adjustments For Depreciation And Amortisation Expense | 55,610,000.00 | N/A | 64,622,000.00 | N/A | 79,532,000.00 | N/A | 97,917,000.00 |
| Adjustments For Impairment Loss Reversal Of Impairment Loss Recognised In Profit Or Loss | 1,004,000.00 | N/A | 1,411,000.00 | N/A | -1,762,000.00 | N/A | 257,000.00 |
| Adjustments For Provisions | 1,344,000.00 | N/A | 0.00 | N/A | 76,115,000.00 | N/A | 1,844,000.00 |
| Adjustments For Unrealised Foreign Exchange Losses Gains | -816,000.00 | N/A | 9,036,000.00 | N/A | 1,702,000.00 | N/A | 3,914,000.00 |
| Adjustments For Sharebased Payments | 3,944,000.00 | N/A | 5,160,000.00 | N/A | 10,550,000.00 | N/A | 11,284,000.00 |
| Adjustments For Fair Value Gains Losses | 0.00 | N/A | 0.00 | N/A | 0.00 | N/A | 0.00 |
| Adjustments For Undistributed Profits Of Associates | -1,288,000.00 | N/A | -2,185,000.00 | N/A | 170,000.00 | N/A | -169,000.00 |
| Adjustments For Losses Gains On Disposal Of Noncurrent Assets | 800,000.00 | N/A | -191,000.00 | N/A | -15,107,000.00 | N/A | -21,286,000.00 |
| Other Adjustments To Reconcile Profit Loss | -1,608,000.00 | N/A | -1,091,000.00 | N/A | -2,476,000.00 | N/A | -2,487,000.00 |
| Adjustments For Reconcile Profit Loss | 71,584,000.00 | N/A | 172,152,000.00 | N/A | 129,737,000.00 | N/A | 214,172,000.00 |
| Cash Flows From Used In Operations | 226,129,000.00 | N/A | 365,600,000.00 | N/A | 331,970,000.00 | N/A | 416,123,000.00 |
| Income Taxes Paid Refund Classified As Operating Activities | 23,882,000.00 | N/A | 40,929,000.00 | N/A | 31,772,000.00 | N/A | 80,186,000.00 |
| Cash Flows From Used In Operating Activities | 202,247,000.00 | N/A | 324,671,000.00 | N/A | 300,198,000.00 | N/A | 335,937,000.00 |
| Cash Flows From Losing Control Of Subsidiaries Or Other Businesses Classified As Investing Activities | 0.00 | N/A | 0.00 | N/A | 0.00 | N/A | 0.00 |
| Cash Flows Used In Obtaining Control Of Subsidiaries Or Other Businesses Classified As Investing Activities | 8,017,000.00 | N/A | 70,013,000.00 | N/A | 123,845,000.00 | N/A | 98,088,000.00 |
| Other Cash Receipts From Sales Of Equity Or Debt Instruments Of Other Entities Classified As Investing Activities | 0.00 | N/A | 0.00 | N/A | 770,000.00 | N/A | 20,272,000.00 |
| Other Cash Payments To Acquire Equity Or Debt Instruments Of Other Entities Classified As Investing Activities | 0.00 | N/A | 546,000.00 | N/A | 6,449,000.00 | N/A | 35,793,000.00 |
| Cash Advances And Loans Made To Other Parties Classified As Investing Activities | 20,426,000.00 | N/A | 10,602,000.00 | N/A | 13,370,000.00 | N/A | 16,343,000.00 |
| Cash Receipts From Repayment Of Advances And Loans Made To Other Parties Classified As Investing Activities | 11,416,000.00 | N/A | 17,749,000.00 | N/A | 23,446,000.00 | N/A | 21,335,000.00 |
| Interest Received Classified As Investing Activities | 2,298,000.00 | N/A | 2,565,000.00 | N/A | 2,628,000.00 | N/A | 5,591,000.00 |
| Cash Flows From Used In Investing Activities | -135,937,000.00 | N/A | -146,914,000.00 | N/A | -145,485,000.00 | N/A | -180,219,000.00 |
| Proceeds From Issuing Shares | 9,219,000.00 | N/A | 34,074,000.00 | N/A | 18,485,000.00 | N/A | 17,331,000.00 |
| Payments To Acquire Or Redeem Entitys Shares | 88,256,000.00 | N/A | 18,237,000.00 | N/A | 55,034,000.00 | N/A | 73,295,000.00 |
| Proceeds From Borrowings Classified As Financing Activities | 118,736,000.00 | N/A | 901,000.00 | N/A | 5,225,000.00 | N/A | 175,309,000.00 |
| Repayments Of Borrowings Classified As Financing Activities | 5,710,000.00 | N/A | 233,769,000.00 | N/A | 1,635,000.00 | N/A | 8,191,000.00 |
| Payments Of Lease Liabilities Classified As Financing Activities | 19,364,000.00 | N/A | 31,897,000.00 | N/A | 25,166,000.00 | N/A | 28,343,000.00 |
| Proceeds From Government Grants Classified As Financing Activities | 1,658,000.00 | N/A | 1,738,000.00 | N/A | 3,835,000.00 | N/A | 5,065,000.00 |
| Dividends Paid Classified As Financing Activities | 32,195,000.00 | N/A | 37,098,000.00 | N/A | 44,166,000.00 | N/A | 51,565,000.00 |
| Interest Paid Classified As Financing Activities | 11,802,000.00 | N/A | 12,625,000.00 | N/A | 10,750,000.00 | N/A | 40,055,000.00 |
| Other Inflows Outflows Of Cash Classified As Financing Activities | 7,716,000.00 | N/A | 62,848,000.00 | N/A | -3,552,000.00 | N/A | -2,892,000.00 |
| Cash Flows From Used In Financing Activities | -19,998,000.00 | N/A | -234,065,000.00 | N/A | -112,758,000.00 | N/A | -6,636,000.00 |
| Increase (decrease) in cash and cash equivalents before effect of exchange rate changes | 46,312,000.00 | N/A | -56,308,000.00 | N/A | 41,955,000.00 | N/A | 149,082,000.00 |
| Effect Of Exchange Rate Changes On Cash And Cash Equivalents | 0.00 | N/A | 0.00 | N/A | 0.00 | N/A | -5,228,000.00 |
| Increase (decrease) in cash and cash equivalents after effect of exchange rate changes | 46,312,000.00 | N/A | -56,308,000.00 | N/A | 41,955,000.00 | N/A | 143,854,000.00 |
| Cash and cash equivalents | 78,914,000.00 | 32,602,000.00 | 22,606,000.00 | 78,914,000.00 | 64,561,000.00 | 22,606,000.00 | 208,415,000.00 |
Please note that some sums might not add up.
PLTRFRM00018
LEI259400KFX90IZ97UDQ91
SectorHealth Care Equipment & Services
IndustryHealth Care Providers & Services
Sub-IndustryKeep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.